Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med1987;316:421-7.
2.
American Heart Association.Jones criteria (revised) for guidance in the diagnosis of rheumatic fever . Circulation1965;32:664-8.
3.
Gordis L., Lilienfeld A., Rodriguez R.Studies in the epidemiology and preventability of rheumatic fever—I: demographic factors and the incidence of acute attacks. J Chronic Dis1969;21:645-54.
4.
Kaplan ELCurrent status of rheumatic fever control programs in the United States. Public Health Rep1981;96:267-8.
5.
Ayoub EM, Barrett DJ, Maclaren NK, Krischer JPAssociation of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest1986;77:2019-26.
6.
Zabriskie JB, Lavenchy D., Williams RC Jr, et al. Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum1985;28:1047-51.
